• Research
  • About
  • Experts
Carnegie India logoCarnegie lettermark logo
Technology
{
  "authors": [
    "Alexander Gabuev",
    "Polina Ivanova",
    "Henry Foy"
  ],
  "type": "commentary",
  "centerAffiliationAll": "",
  "centers": [
    "Carnegie Endowment for International Peace",
    "Carnegie Russia Eurasia Center"
  ],
  "collections": [
    "Coronavirus"
  ],
  "englishNewsletterAll": "",
  "nonEnglishNewsletterAll": "",
  "primaryCenter": "Carnegie Endowment for International Peace",
  "programAffiliation": "",
  "programs": [],
  "projects": [],
  "regions": [],
  "topics": []
}
Commentary

Podcast: Has Russia’s COVID Vaccine Gotten Lost In Politics?

This episode looks at the domestic and international reception of Russia’s Sputnik V vaccine.

Link Copied
By Alexander Gabuev, Polina Ivanova, Henry Foy
Published on Mar 30, 2021

Is Russia’s Sputnik V coronavirus vaccine as successful as the Kremlin claims? Are political considerations really preventing it from getting approval in Western countries? Why is the vaccination rate so low in Russia, and why didn’t Putin get vaccinated sooner? Podcast host Alex Gabuev is joined by Henry Foy, Moscow bureau chief of the Financial Times; and Polina Ivanova, a special correspondent for Reuters in Moscow.

Listen or download: SoundCloud | Subscribe: iTunes, Google Podcasts, Google Play, Spotify, RSS

Authors

Alexander Gabuev
Director, Carnegie Russia Eurasia Center
Alexander Gabuev
Polina Ivanova
Foreign correspondent for the Financial Times
Polina Ivanova
Henry Foy

Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.

More Work from Carnegie India

  • Commentary
    To Help India, Biden Must Unclog the Vaccine Supply Chains

    The United States and many other countries have rushed to send aid to India as the country battles the coronavirus pandemic. But U.S. President Joe Biden needs to focus his administration’s attention on unblocking the congested vaccine supply chain further downstream.

      Rudra Chaudhuri

  • Commentary
    What Is Happening to India’s COVID-19 Vaccine Program?

    India has suffered a devastating new wave of infection from the coronavirus pandemic. As the country races to vaccinate its huge population, what challenges does it face?

      Arjun Kang Joseph

  • Commentary
    To Friends in the United States: Facilitate Global Vaccine Manufacturing

    The COVID-19 crisis in India is devastating. The Biden administration must consider exceptions to the Defense Production Act and ease the global vaccine supply chain.

      • +2

      Arvind Gupta, Rudra Chaudhuri, Harsh Pant, …

  • Research
    South Asia’s Battle With the Coronavirus

    In South Asia, the coronavirus pandemic is at once a public health crisis, an economic crisis, and a humanitarian crisis.

      Rhea Menon, Srinath Raghavan

  • Commentary
    India’s Unheeded Coronavirus Warning

    Early in the outbreak, government researchers forecast several high-risk scenarios that were downplayed or ignored in public messaging.

      Gautam I. Menon

Get more news and analysis from
Carnegie India
Carnegie India logo, white
Unit C-4, 5, 6, EdenparkShaheed Jeet Singh MargNew Delhi – 110016, IndiaPhone: 011-40078687
  • Research
  • About
  • Experts
  • Projects
  • Events
  • Contact
  • Careers
  • Privacy
  • For Media
Get more news and analysis from
Carnegie India
© 2026 Carnegie Endowment for International Peace. All rights reserved.